Catalyst Wire Dossier Catalyst Wire Dossier

EryDex

· Quince Therapeutics S.p.A.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for EryDex, covering 2015-06-01 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension of EryDex Study IEDAT-04-2022 [Phase 3]

See pricing